GlassScriptPhysician profile
Diane H Morrison
NPI 1336220789
$2,345.95
in general payments reported to CMS, 2019-2025
37 companies · $605 in 2025
The $605 reported for 2025 was more than what 84% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $837 · 2020: $132 · 2021: $118 · 2023: $263 · 2024: $391 · 2025: $605.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $230.51 | 2021-2025 | Wegovy, Ozempic |
| Abbvie INC. | $211.50 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $210.12 | 2019-2024 | Gardasil 9, Gardasil, Capvaxive |
| Amgen INC. | $197.65 | 2019-2025 | Repatha, Otezla, Repatha |
| Shield Therapeutics INC | $152.24 | 2023-2025 | Accrufer |
| Lilly USA, LLC | $141.69 | 2021-2025 | Jardiance, Mounjaro, Zepbound |
| Exact Sciences Corporation | $96.45 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Amag Pharmaceuticals, INC. | $85.92 | 2019-2020 | |
| Pfizer INC. | $80.81 | 2019-2025 | |
| Insulet Corporation | $74.96 | 2024-2025 | Omnipod |
| Hologic Sales and Service, LLC | $62.65 | 2019-2025 | Aptima |
| Vertical Pharmaceuticals, LLC | $61.16 | 2019 | |
| Astellas Pharma US INC | $59.08 | 2024 | Veozah |
| Coopersurgical, INC. | $57.85 | 2019-2020 | |
| Indivior INC. | $55.16 | 2024-2025 | Sublocade |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $49.66 | 2019-2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $37.57 | 2025 | Caplyta |
| Boston Scientific Corporation | $37.44 | 2025 | Watchman Flx |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.24 | 2019 | |
| Mission Pharmacal Company | $35.67 | 2019-2020 | |
| Mannkind Corporation | $33.65 | 2025 | |
| Mimedx Group, INC. | $31.07 | 2025 | |
| Therapeuticsmd, INC. | $28.87 | 2019-2020 | |
| Sequel Med Tech, LLC | $27.90 | 2025 | Twiist |
| Phathom Pharmaceuticals, INC. | $27.19 | 2024 | Voquezna |
| Millicent US INC | $25.82 | 2019-2020 | |
| Gilead Sciences, INC. | $25.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $21.65 | 2024 | Rexulti |
| Glaxosmithkline, LLC. | $20.01 | 2023 | Trelegy Ellipta, Shingrix |
| Pharming Healthcare, INC. | $19.42 | 2025 | Ruconest |
| Covidien LP | $19.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $19.24 | 2023 | Airsupra |
| Smith+Nephew, INC. | $15.57 | 2019 | |
| Cepheid | $14.99 | 2025 | |
| Avion Pharmaceuticals | $14.86 | 2019 | |
| Ferring Pharmaceuticals INC. | $13.37 | 2019 | |
| Allergan, INC. | $12.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Morrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.